Non-equity Assistance Funded Biotechnology Startups
The 20 most recent non-equity assistance rounds in biotechnology cover a window from December 2021 through July 2022, with the vast majority of amounts und…
The 20 most recent non-equity assistance rounds in biotechnology cover a window from December 2021 through July 2022, with the vast majority of amounts undisclosed. The four exceptions — Cache (Foster City, CA), CRISP-HR Therapeutics (San Carlos, CA), Rethink Bio (Pune, India), and Neucruit (London, UK) — each received $100K, with Cache, CRISP-HR Therapeutics, and Rethink Bio all dated March 16, 2022.
Date clustering is the most distinctive structural feature of this dataset. Seven companies, including Atom Bioworks (Cary, NC), Dalton Bioanalytics (Los Angeles), and Zymvol Biomodeling (Barcelona), share a July 6, 2022 funding date; six others — among them Digma Medical (Petah Tiqva, Israel), Phagenesis (Manchester), and Lazurite (Cleveland) — were funded on June 7, 2022. This pattern is consistent with batch-award government grant programs that announce recipients simultaneously. California is the leading geography with six companies; seven of the 20 are headquartered outside the United States, spanning Denmark, Canada, Spain, Israel, India, and the United Kingdom.
Most recent rounds
20 shownRelated listings
Frequently asked
What disclosed funding amounts appear among these non-equity assistance biotech rounds?
Of the 20 companies shown, four report a disclosed amount of $100K each: Cache (Foster City, CA), CRISP-HR Therapeutics (San Carlos, CA), and Rethink Bio (Pune, India) — all dated March 16, 2022 — plus Neucruit (London, UK), dated December 8, 2021. The remaining 16 companies list undisclosed amounts. No rounds above $100K appear in this dataset.
Which state has the highest concentration of companies in this segment?
California accounts for six of the 20 companies: Dalton Bioanalytics (Los Angeles), GenNext Technologies (Half Moon Bay), Aqua Medical (Santa Ana), Cari Health (San Diego), Cache (Foster City), and CRISP-HR Therapeutics (San Carlos). Massachusetts is second with three — Organicin Scientific (Amherst), DropGenie (Boston), and RevBio (Lowell).
Why do so many companies share the exact same funding date?
Seven companies were funded on July 6, 2022 — including Atom Bioworks (Cary, NC), DropGenie (Boston), and Zymvol Biomodeling (Barcelona) — and six more share a June 7, 2022 date. Same-day clustering of this scale is characteristic of batch-award government grant programs or accelerator cohorts that announce all recipients at once rather than on a rolling basis.
How many of these biotech companies are headquartered outside the United States?
Seven of the 20 companies are based internationally: Dianox (Copenhagen, Denmark), Ananda Devices (Montréal, Canada), Zymvol Biomodeling (Barcelona, Spain), Digma Medical (Petah Tiqva, Israel), Rethink Bio (Pune, India), Phagenesis (Manchester, UK), and Neucruit (London, UK). The remaining 13 are US-based.
What is the date range covered by these rounds, and how is activity distributed across it?
The oldest round is Neucruit (London), dated December 8, 2021; the most recent is Dianox (Copenhagen), dated July 20, 2022 — a span of roughly seven months. Activity is heavily back-loaded: 15 of the 20 companies received funding in June or July 2022, with only five spread across the preceding six months.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.